Publications

Original Article

Antigen-specific recall urticaria to a peptide-based vaccine

Cancer Vaccines

1999

Authors:

Rinn K, Schiffman K, Otero HO and Disis ML

Journal:

Journal of Allergy and Clinical Immunology

Volume:

104(1)

Page:

240-2

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10400869/

Original Article

Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer

Cancer Vaccines

1999

Authors:

Ward RL, Hawkins NJ, Coomber D, Disis ML

Journal:

Human Immunology

Volume:

60(6)

Page:

510-5

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10408800/

Original Article

Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens

Clinical Trials

1998

Authors:

Disis ML, Shiota FM and Cheever MA

Journal:

Immunology

Volume:

93(2)

Page:

192-9

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/9616368/

Original Article

Immunization of metastatic breast cancer patients with CD80-modified breast cancer cells and GM-CSF

Clinical Trials

1998

Authors:

Schoof DD, Smith JW 2nd, Disis ML, Brant-Zawadski P, Wood W, Doran T, Johnson E Ubra WJ

Journal:

Gene Therapy of Cancer

Volume:

451

Page:

511-8

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/10026920/

Review Article

HER-2/neu oncogenic protein: issues in vaccine development

Cancer Vaccines

1998

Authors:

Disis ML and Cheever MA

Journal:

Critical Reviews in Immunology

Volume:

18(1-2)

Page:

37-45

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/9419446/

Original Article

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8

Cancer Vaccines

1997

Authors:

Lustgarten J, Theobald M, Labadie C, LaFace D, Peterson P, Disis ML, Cheever MA and Sherman LA

Journal:

Human Immunology

Volume:

52(2)

Page:

109-18

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/9077559/

Review Article

HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer

Cancer Vaccines

1997

Authors:

Disis ML and Cheever MA

Journal:

Advances in Cancer Research

Volume:

Page:

343-71

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/9111870/

Original Article

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

Cancer Vaccines

1997

Authors:

Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S and Cheever MA

Journal:

Journal of Clinical Oncology

Volume:

15(11)

Page:

3363-7

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/9363867/

Review Article

In vitro priming to tumor-associated proteins

T Cell Function & Therapy

1997

Authors:

Hand SL, Bernhard H, Huseby ES, Rubin WD, Disis ML, and Cheever MA

Journal:

Advances in Experimental Medicine and Biology

Volume:

417

Page:

503-9

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/9286411/

Original Article

Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein

Cancer Vaccines

1996

Authors:

Disis ML, Gralow JA, Bernhard H, Hand SL, Rubin WD, Cheever MA

Journal:

Journal of Immunology

Volume:

156(9)

Page:

3151-8

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/8617935/